S&P・Nasdaq 本質的価値 お問い合わせ
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← 全銘柄に戻る

NovoCure Limited NVCR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • JE • USD

SharesGrow Score
51/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$33.50
+196.5%

合計 50 件の最近のインサイダー取引記録が記録されています NovoCure Limited (NVCR), 内訳は 26 件の買い および 21 件の売り. インサイダー買い総額は $9.91M インサイダー売り総額は $2.01M.

最近活動のある主要インサイダーには Paravasthu Mukund, Weinberg Uri, Cordova Ashley. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.

インサイダー取引記録 — NVCR

日付 氏名 役職 取引種別 株数 平均価格 価値 保有株数
2026-03-05 Paravasthu Mukund Chief Operating Officer 情報に基づく売り 43,246 $13.77 $595.67K 72,832
2026-03-04 Weinberg Uri Chf Medical and Innovation Ofr 情報に基づく売り 6,412 $13.31 $85.31K 267,190
2026-03-04 Cordova Ashley Former Chief Executive Officer RSU 源泉徴収 17,638 $13.30 $234.59K 422,570
2026-03-04 Leonard Frank X Chief Executive Officer 情報に基づく売り 5,607 $13.31 $74.6K 493,793
2026-03-04 Puri Michal Nath Chief Human Resources Officer 情報に基づく売り 1,100 $13.31 $14.64K 201,322
2026-03-04 Leupin Nicolas Former Chief Medical Officer 情報に基づく売り 1,100 $13.31 $14.64K 102,979
2026-03-04 Paravasthu Mukund Chief Operating Officer 情報に基づく売り 5,377 $13.31 $71.54K 116,078
2026-03-04 Brackmann Christoph Chief Financial Officer 情報に基づく売り 6,412 $13.31 $85.31K 182,842
2026-03-03 Doyle William F Executive Chairman RSU 付与（制限付株式） 200,000 - - 200,000
2026-03-03 Weinberg Uri Chf Medical and Innovation Ofr RSU 付与（制限付株式） 73,340 $13.30 $975.42K 73,340
2026-03-03 Leonard Frank X Chief Executive Officer RSU 付与（制限付株式） 216,388 $13.30 $2.88M 216,388
2026-03-03 Ben Arye Barak General Counsel RSU 付与（制限付株式） 73,340 $13.30 $975.42K 73,340
2026-03-03 Puri Michal Nath Chief Human Resources Officer RSU 付与（制限付株式） 58,672 $13.30 $780.34K 58,672
2026-03-03 Paravasthu Mukund Chief Operating Officer RSU 付与（制限付株式） 7,518 $13.30 $99.99K 7,518
2026-03-03 Brackmann Christoph Chief Financial Officer RSU 付与（制限付株式） 80,674 $13.30 $1.07M 80,674
2026-03-02 Weinberg Uri Chf Medical and Innovation Ofr 情報に基づく売り 3,272 $13.33 $43.61K 223,477
2026-03-02 Cordova Ashley Former Chief Executive Officer RSU 源泉徴収 7,228 $13.67 $98.81K 440,208
2026-03-02 Leonard Frank X Chief Executive Officer 情報に基づく売り 7,232 $13.49 $97.58K 349,400
2026-02-28 Weinberg Uri Chf Medical and Innovation Ofr RSU 付与（制限付株式） 12,992 - - 226,749
2026-02-28 Cordova Ashley Former Chief Executive Officer RSU 付与（制限付株式） 23,818 - - 449,846
2026-02-28 Leonard Frank X Chief Executive Officer RSU 付与（制限付株式） 18,621 - - 356,632
2026-02-28 Ben Arye Barak General Counsel RSU 付与（制限付株式） 17,755 - - 192,328
2026-02-27 Weinberg Uri Chf Medical and Innovation Ofr 情報に基づく売り 7,461 $13.84 $103.26K 213,757
2026-02-27 Cordova Ashley Former Chief Executive Officer RSU 源泉徴収 11,541 $13.75 $158.69K 426,028
2026-02-27 Leonard Frank X Chief Executive Officer 情報に基づく売り 9,734 $13.66 $133K 338,011
2026-02-27 Puri Michal Nath Chief Human Resources Officer 情報に基づく売り 1,441 $13.66 $19.69K 162,322
2026-01-11 Paravasthu Mukund Chief Operating Officer RSU 源泉徴収 2,133 $14.35 $30.61K 78,306
2025-12-31 Danziger Asaf Officer 不明 - - - -
2025-12-31 Ben Arye Barak Officer 不明 - - - -
2025-12-31 Puri Michal Nath Officer 不明 - - - -
2025-11-04 Paravasthu Mukund Chief Operating Officer RSU 源泉徴収 2,949 $12.23 $36.07K 80,439
2025-11-04 Brackmann Christoph Chief Financial Officer RSU 源泉徴収 7,033 $12.23 $86.01K 134,117
2025-11-01 Leonard Frank X EVP, Pres., Novocure Oncology RSU 源泉徴収 966 $12.81 $12.37K 347,745
2025-11-01 Paravasthu Mukund Chief Operating Officer RSU 源泉徴収 168 $12.81 $2.15K 83,388
2025-10-31 Puri Michal Nath Chief Human Resources Officer RSU 源泉徴収 752 $12.82 $9.64K 163,762
2025-09-05 Cordova Ashley Chief Executive Officer 情報に基づく買い 81,550 $12.22 $996.86K 437,569
2025-07-29 Brackmann Christoph Chief Financial Officer 情報に基づく買い 10,000 $11.63 $116.3K 131,150
2025-06-30 Danziger Asaf Director RSU 付与（制限付株式） 833 $15.13 $12.6K 416,473
2025-06-30 Cordova Ashley Chief Executive Officer RSU 付与（制限付株式） 833 $15.13 $12.6K 356,019
2025-06-30 Leonard Frank X EVP, Pres., Novocure Oncology RSU 付与（制限付株式） 833 $15.13 $12.6K 348,711
2025-06-30 Ben Arye Barak General Counsel RSU 付与（制限付株式） 769 $15.13 $11.63K 174,465
2025-06-30 Puri Michal Nath Chief Human Resources Officer RSU 付与（制限付株式） 833 $15.13 $12.6K 164,514
2025-06-04 Hilleman Jeryl L Director RSU 付与（制限付株式） 16,697 $16.72 $279.17K 16,697
2025-06-04 Leung Gabriel Director RSU 付与（制限付株式） 16,697 $16.72 $279.17K 16,697
2025-06-04 Hung David Director RSU 付与（制限付株式） 16,697 $16.72 $279.17K 16,697
2025-06-04 Vernon W Anthony Director RSU 付与（制限付株式） 16,697 $16.72 $279.17K 16,697
2025-06-04 Scannell Timothy J Director RSU 付与（制限付株式） 16,697 $16.72 $279.17K 16,697
2025-06-04 Madden Martin J. Director RSU 付与（制限付株式） 33,393 $16.72 $558.33K 33,393
2025-06-04 Leonard Frank X EVP, Pres., Novocure Oncology RSU 付与（制限付株式） 179,426 - - 347,878
2025-06-04 Ocean Allyson J Director RSU 付与（制限付株式） 11,215 - - 14,269
■ 情報付き — 公開市場取引（最も重要） ■ 情報なし（買い） — 報酬・オプション行使・転換 ■ 情報なし（売り） — 源泉徴収・付与売却 ■ 中立 — 贈与・信託・失効

他のユーザーも閲覧

PODD
PODD
Insulet Corporation
$201.49
+1.86%
 PEN
PEN
Penumbra, Inc.
$332.17
+0.21%
 GMED
GMED
Globus Medical, Inc.
$94.94
+2.11%
 SWAV
SWAV
ShockWave Medical, Inc.
$334.75
-0.02%
 MASI
MASI
Masimo Corporation
$178.39
-0.04%
 NARI
NARI
Inari Medical, Inc.
$79.97
+0.00%
 IRTC
IRTC
iRhythm Technologies, Inc.
$123.23
+2.31%
 TMDX
TMDX
TransMedics Group, Inc.
$115.68
+2.05%
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
📧 [email protected]
📞 +65 8912 8000
メッセージを送る